Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
755 trials across Europe, recruiting first
A Study of Long-Term Safety of Teplizumab in Children and Adolescents with Recently Diagnosed Type 1 Diabetes
BelgiumStudy on the Effects of AZD5004 for Adults with Obesity or Overweight and a Related Medical Condition
GermanyStudy of dasatinib and quercetin combination for treating liver fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
The NetherlandsStudy on Preventing Low Calcium Levels After Thyroid Surgery with Preoperative Cholecalciferol Supplementation for Patients Undergoing Total Thyroidectomy
FranceStudy on the Effectiveness of ODM-111 and Paracetamol for Chronic Pain in Patients with Diabetic Peripheral Neuropathy
BulgariaStudy on Managing High Cholesterol in Cardiovascular Disease Patients Using Inclisiran
HungaryStudy on the Effects of Leriglitazone for Adult Men with Cerebral Adrenoleukodystrophy
FranceStudy on Ixekizumab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients
SwedenStudy on the Safety and Tolerability of VRDN-001 for Patients with Thyroid Eye Disease
FranceStudy on the Safety and Effectiveness of Hydroxypropylbetadex and Miglustat for Patients with Niemann-Pick Disease Type C1
GermanyStudy on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema
AustriaThe therapies tested most often in Metabolism and nutrition disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
